Expression of Aldehyde Dehydrogenase 1A1 in Relapse-Associated Cells in Acute Myeloid Leukemia
In acute myeloid leukemia (AML) it is important to elucidate the biological events that lead from remission to relapse, which have a high probability of leading to an adverse disease outcome. The cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1A1) is underexpressed in AML cells when compared...
Saved in:
Main Authors: | Régis Costello, Garrett M. Dancik, Anaïs Dubiau, Lamia Madaci, Spiros Vlahopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/13/1038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia
by: Jiawen Wang, et al.
Published: (2025-12-01) -
PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis
by: Yueh-Chwen Hsu, et al.
Published: (2025-09-01) -
Multiple roles of ALDH1 in health and disease
by: Wenqi Zhao, et al.
Published: (2025-07-01) -
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
by: G. A. Radzhabova, et al.
Published: (2025-03-01) -
Functional Characterization of an Aldehyde Dehydrogenase Homologue in Rice
by: Sheng-hui YANG, et al.
Published: (2012-09-01)